Abbott Backs Down In Kaletra Pricing Fight
Abbott Laboratories said Tuesday it will slash the price of Kaletra by more than half in a slew of developing nations, following months of international pressure over the pharmaceutical giant's drug...To view the full article, register now.
Already a subscriber? Click here to view full article